V

VYNE Therapeutics
D

VYNE

2.74000
USD
0.04
(1.63%)
مغلق
حجم التداول
3,477
الربح لكل سهم
-1
العائد الربحي
-
P/E
1
حجم السوق
40,418,926
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALKS
    -0.240
    (-0.68%)
    35.260 USD
    A
    ANIK
    -0.250
    (-1.42%)
    17.390 USD
    A
    ARGX
    -2.16
    (-0.33%)
    645.20 USD
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    D
    DERM
    0.02000
    (0.39%)
    5.16000 USD
    E
    EOLS
    -0.630
    (-4.31%)
    13.990 USD
    المزيد
الأخبار
المقالات

العنوان: VYNE Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.